The once-daily nucleotide sofosbuvir plus ribavirin (RBV) was assessed in FISSION study while sofosbuvir plus ribavirin and pegylated interferon was assessed in NEUTRINO study in chronic HCV infected
The GOBIOM database assists FDA in its biomarker qualification process by providing most recent information on all the clinically evaluated, exploratory and preclinical biomarkers reported in a range
The firm’s ADCETRIS is the first in a new class of antibody-drug conjugates (ADCs) used for the Treatment of Relapsed or Refractory Hodgkin Lymphoma (HL) and Systemic Anaplastic
The decree was signed by US District Court for the Northern District judge Lesley Wells of Ohio on 31 January 2013 and was issued to Ben Venue’s chief
RAVICTI used for treating Urea Cycle Disorders (UCD) in patients two years of age and older, is expected to be commercially available by the end of April 2013.
CRLX101, a tumor-targeted nanopharmaceutical, is a dual inhibitor of topoisomerase 1 and hypoxia-inducible factor-1a and releases camptothecin over an extended period of time. The randomized study, which is
Under the agreement, MDH will utilize Sectra Breast Imaging PACS to provide remote reading of mammograms to its customers. The agreement also covers Volpara’s integrated breast density software,
Oxtellar XR, a once-daily extended release formulation of oxcarbazepine, is an antiepileptic drug (AED), which is available in 150 mg, 300 mg and 600 mg dosage strengths. The
The partnership will deliver more robust, insight-based strategic RM outcomes by leveraging Appature’s enablement of Big Data and cloud-based marketing platform and DKI’s expertise in building meaningful relationship
The company leverages 3D bioreactor technology in the production of the PLX cells to tackle issues such as reproducibility, production costs and quality. Pluristem chairman and CEO Zami
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.